News and Media | MirZyme Therapeutics

Investors

MirZyme has zero debt and is financed by equity. The company intends to progress each of its pipeline of patented products in a way that those that will generate income in the shorter term can finance the development of those that will take longer to bring to market.

News and Media

MirZyme

Dec 16, 2020

Two breakthrough studies show a hydrogen sulfide drug prevents preeclampsia

Preeclampsia is a life-threatening pregnancy disorder affecting one in twelve of 130 million annual pregnancies worldwide and causes the...

MirZyme

Nov 16, 2020

MirZyme Therapeutics partners with King Abdulaziz University

MirZyme Therapeutics partners with King Abdulaziz University to accelerate the development of targeted therapeutics using artificial...

MirZyme

Oct 24, 2020

Scientists at MirZyme have developed a breakthrough ‘miracle’ cure for preeclampsia

PRESS RELEASE Scientists at MirZyme Therapeutics have discovered a cure for preeclampsia, a life- threatening hypertensive disorder...

MirZyme

Jan 15, 2019

Europe’s New Roadmap for a Healthier Pregnancy

The death of Lady Sybil during childbirth in the BBC period drama ‘Downton Abbey’ highlighted the risky business of pregnancy caused by...

MirZyme

Aug 9, 2015

The statin that saves babies from stillbirth

Discovery could save pregnant women from potentially fatal high blood pressure condition. A statin used to lower cholesterol could also...

MirZyme

May 28, 2013

Breakthrough in fight against pre-eclampsia: Scientists may have found cause of the life-threatening

Scientists may have found the cause of the life-threatening pregnancy condition pre-eclampsia – using a gas that smells like rotten eggs....

Publications

Click here for publications